September 2, 2015 | HeartWare International announced that it has entered into a definitive agreement to acquire Valtech Cardio in a share deal. According to reports, Valtech’s shares could be worth as much as $800 million. Valtech develops a number of non-invasive solutions for the treatment of heart conditions. Valtech was founded in 1996 by CEO Yossi Gross and Yiftach Beinart.
Related posts
Israeli Startups Create Powerful Drone-Detecting Software
September 28, 2023
Model Sees Daylight As Boost For Hospitalized Patients’ Health
September 28, 2023
Solar Panels On A Roll Certified As Safe For Use In US, Europe
September 28, 2023
US Soldiers, Vets To Get Israeli-Made Helmets To Treat Depression
September 27, 2023
Facebook comments